| 1359 |
National Cancer Institute |
Html |
en |
Cancer Pain (PDQ®)–Health Professional Version |
Expert-reviewed information summary about pain as a complication of cancer or its treatment. Approaches to the management and treatment of cancer-associated pain are discussed. |
| initial pain assessment | 0.567168 |
| baseline pain intensity | 0.558291 |
| treats mild pain | 0.559952 |
| moderate cancer pain | 0.617809 |
| metastatic bone pain | 0.57198 |
| incident cancer pain | 0.559612 |
| acute pain resolves | 0.55829 |
| pain management treatment | 0.568663 |
| ongoing pain management | 0.552517 |
| pain relief ladder | 0.55951 |
| common cancer pain | 0.591113 |
| Neuropathic Pain sections | 0.560808 |
| somatic pain | 0.561569 |
| indicates mild pain | 0.560721 |
| cancer patients | 0.628525 |
| pain intensity | 0.56637 |
| pain management | 0.652391 |
| neuropathic pain | 0.592568 |
| Pain Symptom Manage | 0.699092 |
| cancer pain control | 0.556765 |
| Pain Management Nursing | 0.556277 |
| Pain Physician | 0.561182 |
| pain assessment | 0.597079 |
| Pain Palliat Care | 0.567356 |
| breakthrough cancer pain | 0.563775 |
|
| visceral pain signals | 0.562249 |
| severe cancer pain | 0.582593 |
| PUBMED Abstract | 0.564761 |
| visceral pain | 0.565502 |
| pain assessment toolkit | 0.554382 |
| mild pain | 0.57672 |
| Effective pain management | 0.567467 |
| cancer pain management | 0.592002 |
| pain relief | 0.569023 |
| moderate pain | 0.568137 |
| cancer pain | 0.834476 |
| American Pain Society | 0.557173 |
| pain | 0.954306 |
| acute pain | 0.572092 |
| Abstract | 0.595673 |
| Pain Med | 0.572479 |
| Clin Oncol | 0.552396 |
| severe pain | 0.584777 |
| cancer pain experience | 0.579997 |
| pain scale | 0.566028 |
| pain levels | 0.565618 |
| comprehensive pain assessment | 0.576005 |
| indicates moderate pain | 0.564768 |
| pain receptors | 0.555011 |
|
CLICK HERE |
| 1415 |
National Cancer Institute |
Html |
en |
Grief, Bereavement, and Coping With Loss (PDQ®)–Patient Version |
Expert-reviewed report about grief, bereavement, and feelings of loss in survivors of someone who has died of cancer. Grief in children is also discussed. |
| normal grief process | 0.471417 |
| Common grief reactions | 0.532686 |
| grief pattern | 0.454756 |
| bereaved person moves | 0.399208 |
| family member | 0.390974 |
| PDQ cancer information | 0.489866 |
| unexpected loss | 0.387668 |
| loss | 0.666269 |
| children | 0.561087 |
| typical grief response | 0.466341 |
| PDQ Grief | 0.446846 |
| clinical trials | 0.426876 |
| grief | 0.931776 |
| anticipatory grief | 0.60415 |
| cancer information summary | 0.442789 |
| social support | 0.46161 |
| clinical trial | 0.441424 |
| younger bereaved people | 0.426523 |
| family members | 0.386464 |
| Grief bursts | 0.441053 |
| weight loss | 0.372081 |
| bereaved people | 0.499808 |
| severe grief | 0.457196 |
| difficult grief | 0.440844 |
|
| NCI PDQ cancer | 0.383634 |
| grief reactions | 0.581886 |
| person | 0.556278 |
| grief symptoms | 0.442678 |
| deceased person | 0.373691 |
| child | 0.531789 |
| distress | 0.378808 |
| normal grief | 0.541883 |
| death | 0.826955 |
| Chronic grief | 0.43943 |
| Cancer Information Service | 0.369255 |
| complicated grief | 0.451713 |
| National Cancer Institute | 0.448538 |
| health care | 0.379094 |
| grief process | 0.5341 |
| Palliative Care Editorial | 0.392193 |
| new treatment | 0.370063 |
| different cultures | 0.372731 |
| Care Editorial Board | 0.393341 |
| people | 0.580964 |
| way | 0.395094 |
| grief treatment | 0.44457 |
| comprehensive cancer information | 0.368169 |
| depression | 0.378859 |
|
CLICK HERE |
| 1735 |
National Cancer Institute |
Html |
en |
Reproductive History and Cancer Risk |
A fact sheet that describes what is known about the relationship between pregnancy, miscarriage, abortion, fertility treatment and the risk of cancer. |
| spontaneous abortion | 0.436313 |
| additional full-term pregnancy | 0.438399 |
| reproductive factors | 0.477411 |
| British Journal | 0.464068 |
| Breast Cancer Research | 0.554497 |
| Long-term cancer risk | 0.463368 |
| reduced risk | 0.446487 |
| ovarian cancer | 0.487507 |
| Smalley M. Pregnancy | 0.434754 |
| future breast cancer | 0.499324 |
| pregnancy | 0.509986 |
| lower risk | 0.435353 |
| cancer types | 0.43982 |
| receptor-negative breast cancer | 0.516576 |
| maternal breast cancer | 0.498304 |
| slightly higher risk | 0.457714 |
| Cancer Epidemiology | 0.469709 |
| ovarian stimulation | 0.442204 |
| breast cancer declines | 0.516281 |
| endometrial cancer | 0.444521 |
| International Journal | 0.437218 |
| women | 0.502711 |
| risk reduction | 0.435107 |
| ovarian hormones | 0.434429 |
| invasive ovarian cancer | 0.459634 |
|
| breast cells | 0.485604 |
| decreased risk | 0.446489 |
| cancer cells | 0.451518 |
| Breast cancer incidence | 0.495609 |
| full-term pregnancy | 0.496243 |
| Endocrine-Related Cancer | 0.440218 |
| breast tissue | 0.475053 |
| studies | 0.44347 |
| epithelial ovarian cancer | 0.455081 |
| ovarian cancer risk | 0.471705 |
| epidemiological studies | 0.438401 |
| higher risk | 0.46047 |
| endocrine-related risk factors | 0.447705 |
| breast cancer risk | 0.823683 |
| receptor–positive breast cancer | 0.54092 |
| breast cancer | 0.983763 |
| van leeuwen fe | 0.44337 |
| pregnancy-related factors | 0.45934 |
| vitro fertilization | 0.434549 |
| Colditz GA | 0.436762 |
| fertility drugs | 0.477238 |
| receptor–negative breast cancers | 0.493334 |
| et al | 0.597414 |
| Vatten LJ | 0.446247 |
|
CLICK HERE |
| 2028 |
National Cancer Institute |
Html |
es |
Exámenes de detección del cáncer colorrectal (PDQ®)–Versión para profesionales de salud |
Sumario de información revisada por expertos sobre las pruebas que se usan para detectar el cáncer colorrectal. |
| accessed july | 0.61974 |
| materia fecal versus | 0.569405 |
| Cancer Statistics Review | 0.717463 |
| American Cancer Society | 0.622678 |
| prueba gfobt hemoccult-ii | 0.559469 |
| FOBT bienales | 0.553931 |
| colon distal | 0.622974 |
| Winawer SJ | 0.556908 |
| colorectal cancer | 0.922778 |
| tubo gi | 0.54546 |
| ensayo danés | 0.593036 |
| Estados Unidos | 0.603591 |
| Cancer Incidence | 0.540817 |
| IC 95Â %)Riesgo | 0.584646 |
| prueba fobt | 0.659659 |
| Sin efecto | 0.549689 |
| fecal occult blood | 0.562549 |
| detección norccap | 0.581363 |
| pruebas fobt | 0.558088 |
| SEER Cancer Statistics | 0.726137 |
| incidencia mortalidad | 0.623577 |
| cancer screening | 0.585359 |
| siguientes ciclos | 0.545695 |
| prueba gFOBT | 0.591796 |
| reino unido | 0.63003 |
|
| detección diseño | 0.605975 |
| CCR Validez | 0.68242 |
| Dukes C | 0.550116 |
| Cancer Facts | 0.543305 |
| Dukes D | 0.548677 |
| Colonoscopia Estudios | 0.59156 |
| automatizados tipo fit | 0.569845 |
| Colorectal Cancer Prevention | 0.562051 |
| Noone AM | 0.6798 |
| National Polyp Study | 0.591363 |
| PaÃses Bajos | 0.569859 |
| vÃas respiratorias | 0.55455 |
| National Cancer Institute | 0.711885 |
| Rozen P | 0.556076 |
| %)c incidencia | 0.544729 |
| Levin B | 0.551596 |
| exámenes bienales | 0.563089 |
| Sin rehidratación | 0.656137 |
| Krapcho M | 0.597589 |
| colonoscopia versus | 0.571346 |
| análisis fit | 0.820245 |
| sigmoidoscopia detecta lesiones | 0.562884 |
| Cancer Screening Trial | 0.547357 |
| adenomas distales versus | 0.573736 |
|
CLICK HERE |
| 3421 |
National Cancer Institute |
Html |
es |
Antioxidantes y prevención del cáncer |
Antioxidants are substances that may protect cells from the damage caused by unstable molecules known as free radicals. Free radical damage may lead to cancer. Antioxidants interact with and stabilize free radicals and may prevent some of the damage fre |
| nutrition intervention trial | 0.318966 |
| Population Nutrition Intervention | 0.307215 |
| Minerales Antioxidantes | 0.329026 |
| mortality during | 0.312847 |
| skin cancers | 0.309111 |
| Hercberg S | 0.31386 |
| complementos antioxidantes alimenticios | 0.358441 |
| vitamina c | 0.306663 |
| vitamina a | 0.307237 |
| Klein EA | 0.307093 |
| vitamina e | 0.306864 |
| Virtamo J | 0.307865 |
| mortality after | 0.306705 |
| antioxidantes alimenticios | 0.533634 |
| stopping antioxidant vitamins | 0.315828 |
| Internal Medicine | 0.308526 |
| Estados Unidos | 0.333664 |
| antioxidant vitamins | 0.315879 |
| PubMed Abstract | 0.94039 |
| Estudio Demográfico | 0.30775 |
| follow-up after stopping | 0.328778 |
| after stopping antioxidant | 0.315902 |
| skin cancers during | 0.306731 |
| minerales selenio | 0.30885 |
| health beneficial effects | 0.308495 |
|
| randomized controlled | 0.317735 |
| International Journal | 0.310662 |
| health effects | 0.306579 |
| Kristal AR | 0.308705 |
| tomar complementos | 0.660547 |
| Taylor PR | 0.316391 |
| Ezzedine K | 0.307269 |
| general population | 0.307041 |
| supplemental alpha-tocopherol | 0.309241 |
| Kesse-Guyot E | 0.307458 |
| tract cancers | 0.32431 |
| médicos varones | 0.307704 |
| beta carotene | 0.315537 |
| elemento mineral selenio | 0.311109 |
| Cancer Prevention Study | 0.31922 |
| Cancer Prevention Trial | 0.339926 |
| complementos alimenticios | 0.353561 |
| retinol efficacy trial | 0.343648 |
| SU.VI.MAX Study | 0.30914 |
| radicales libres | 0.808852 |
| resultados mixtos | 0.310828 |
| Cancer Institute | 0.352968 |
| New England Journal | 0.317494 |
| Cancer Prevention | 0.362527 |
|
CLICK HERE |
| 3565 |
National Cancer Institute |
Html |
en |
Funding Opportunities |
Find a wide range of funding announcements to support cancer research and training, organized by topic and by funding mechanism. |
| population sciences | 0.493717 |
| promising research areas | 0.56879 |
| research grants | 0.500944 |
| AIDS-related cancer | 0.494918 |
| Cancer Clinical Proteomics | 0.567175 |
| Cancer Complementary | 0.503257 |
| mutant RAS-driven cancers | 0.494379 |
| Cancer Moonshot Blue | 0.59594 |
| Cancer Nanotechnology Research | 0.679363 |
| Cancer program | 0.497422 |
| research community | 0.507936 |
| cancer patients | 0.484719 |
| Research projects | 0.502551 |
| Basic cancer research | 0.680007 |
| Tissue Sample Collection | 0.485994 |
| Reduce Cancer Health | 0.579079 |
| Trans-NIH Research Project | 0.629695 |
| Cancer Health Disparities | 0.713271 |
| surveillance cancer research | 0.666086 |
| basic cancer biology | 0.601818 |
| Cancer Control | 0.538781 |
| biostatistical funding opportunities | 0.51758 |
| Cancer Moonshotâ„ Funding | 0.624526 |
| Ribbon Panel recommendations | 0.479686 |
|
| cancer prevention | 0.563482 |
| Cancer Treatment | 0.485294 |
| epidemiological research | 0.487712 |
| alternative medicine practice | 0.49686 |
| NCI Alliance | 0.464504 |
| Provocative Questions Program | 0.51458 |
| cancer research | 0.973473 |
| treat cancer | 0.476905 |
| recent NCI-supported RFAs | 0.522382 |
| cancer screening procedures | 0.560144 |
| alternative medicine | 0.550525 |
| Analysis Technologies Program | 0.493099 |
| small business | 0.635559 |
| private sector participation | 0.462098 |
| health disparities perspective | 0.521069 |
| RAS Initiative enlists | 0.522897 |
| Outstanding Investigator Award | 0.657445 |
| NCI initiative | 0.486583 |
| Biospecimen Research Branch | 0.595175 |
| Business Innovation Research | 0.566067 |
| Translational Research | 0.497403 |
| Business Technology Transfer | 0.60463 |
| Small Business Technology | 0.604737 |
| research communities | 0.503329 |
|
CLICK HERE |
| 16662 |
National Cancer Institute |
Html |
es |
Qué son el “cerebro en quimio” y el deterioro cognoscitivo después de tratamiento de cáncer |
Actualización acerca de la investigación de los factores que tienen una función en el |
| gen apoe | 0.427379 |
| información meses | 0.42886 |
| ¿estos problemas | 0.43724 |
| doctor ahles | 0.800077 |
| peor desempeño | 0.428323 |
| recientes investigaciones | 0.427457 |
| gemelos idénticos —una | 0.452424 |
| larga duración | 0.464561 |
| cuáles pacientes | 0.458793 |
| edad afÃn | 0.424345 |
| variado deterioro | 0.472498 |
| Wilmot Cancer Institute | 0.444334 |
| Funciones Cognoscitivas | 0.442034 |
| gen bdnf | 0.427202 |
|
| doctor tim ahles | 0.462437 |
| oncológico integral jonsson | 0.458544 |
| llamada evaluación funcional | 0.440824 |
| antidepresivo fluoxetina | 0.426333 |
| sistema nervioso central | 0.4425 |
| doctora rowland | 0.544141 |
| actividad neurotransmisor | 0.425054 |
| doctora patricia ganz | 0.777152 |
| Oncológico Memorial Sloan | 0.455699 |
| doctora julia rowland | 0.500519 |
| quimioterapia 5-FU | 0.47139 |
| doctora michelle janelsins | 0.489763 |
| gen comt | 0.425879 |
|
CLICK HERE |
| 17188 |
National Cancer Institute |
Html |
en |
Fertility Issues in Boys and Men with Cancer |
Fertility issues are common in boys and men getting cancer treatment. Fertility preservation options include sperm banking, testicular shielding, testicular sperm extraction (TESE), and testicular tissue freezing. Support and clinical trials are listed. |
| Sexual Health Issues | 0.508548 |
| cancer treatment | 0.619036 |
| fertility | 0.97146 |
| baseline fertility | 0.628851 |
| family member | 0.464194 |
| cancer therapy | 0.481706 |
| health care team | 0.501109 |
| sperm counts | 0.505642 |
| fertility problems | 0.606189 |
| stem cell transplants | 0.576694 |
| upsetting long-term effects | 0.50079 |
| Sperm banking | 0.500128 |
| Testicular tissue freezing | 0.505046 |
| specific treatment | 0.473076 |
| fertility clinic | 0.610475 |
| professionally led support | 0.49722 |
| sperm-forming cells | 0.50982 |
| reproductive endocrinologist | 0.471953 |
| fertility options | 0.634938 |
| fertility preservation procedures | 0.624595 |
| Testicular sperm extraction | 0.553558 |
| radiation therapy | 0.551741 |
| testicular shielding | 0.519544 |
| sperm cells | 0.508932 |
| Reproductive Medicine | 0.463459 |
|
| cancer treatments | 0.62693 |
| blood stem cell | 0.500463 |
| personal health factors | 0.507399 |
| fertility preservation options | 0.794614 |
| testicular tissue cryopreservation | 0.506676 |
| scatter radiation | 0.468354 |
| male cancer patients | 0.603613 |
| fertility preservation | 0.823931 |
| young male cancer | 0.600402 |
| fertility risks | 0.574477 |
| LIVESTRONG Fertility | 0.586472 |
| rectal cancer | 0.479468 |
| reproductive age | 0.463816 |
| sperm | 0.578609 |
| infertility | 0.495824 |
| doctor | 0.471639 |
| fertility specialist | 0.642942 |
| reproductive medical information | 0.506006 |
| cancer | 0.662671 |
| fertility preservation clinic | 0.634592 |
| fertility preservation discounts | 0.62021 |
| bone marrow transplants | 0.501862 |
| child’s doctor | 0.462088 |
| reproductive organs | 0.558126 |
|
CLICK HERE |
| 17281 |
National Cancer Institute |
Html |
es |
Superar sus sentimientos |
Las personas con cáncer avanzado tienen algunos sentimientos en común. Usted verá que no está solo cuando le toque enfrentar estos sentimientos. |
|
|
CLICK HERE |
| 17283 |
National Cancer Institute |
Html |
es |
Instrucciones por adelantado |
Información sobre las instrucciones por adelantado, los cuales son documentos legales que le permiten a usted decidir con anticipación como desea que le brinden atención médica. |
| organización nacional | 0.667013 |
| aging with dignity | 0.502826 |
| resumidas cuentas | 0.476767 |
| American Bar Association | 0.490541 |
| Cinco deseos | 0.457338 |
|
| Five Wishes | 0.456319 |
| Voicing My Choices | 0.497173 |
| cuidados paliativos | 0.908507 |
| Mucha gente | 0.472554 |
|
CLICK HERE |